Michael McDermott

62.3k total citations · 10 hit papers
630 papers, 33.4k citations indexed

About

Michael McDermott is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Michael McDermott has authored 630 papers receiving a total of 33.4k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Molecular Biology, 109 papers in Neurology and 82 papers in Immunology. Recurrent topics in Michael McDermott's work include Inflammasome and immune disorders (79 papers), Parkinson's Disease Mechanisms and Treatments (41 papers) and Genetic Neurodegenerative Diseases (36 papers). Michael McDermott is often cited by papers focused on Inflammasome and immune disorders (79 papers), Parkinson's Disease Mechanisms and Treatments (41 papers) and Genetic Neurodegenerative Diseases (36 papers). Michael McDermott collaborates with scholars based in United States, United Kingdom and Ireland. Michael McDermott's co-authors include Philip N. Hawkins, Dennis McGonagle, Lisa M. Sedger, Jürg Tschopp, Fabio Martinon, Karl Kieburtz, Kimberly Burns, Laetitia Agostini, Flemming Pociot and Leigh D Church and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Michael McDermott

612 papers receiving 32.4k citations

Hit Papers

NALP3 Forms an IL-1β-Processing Inflammasome with ... 1988 2026 2000 2013 2004 1990 1999 1988 2014 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
    2004 1.4k citations Fabio Martinon, Michael McDermott et al. profile →
  2. Variable expression of Parkinson's disease
    1990 1.0k citations Michael McDermott et al. profile →
  3. Cytokine gene polymorphism in human disease: on-line databases
    1999 708 citations Michael McDermott et al. Genes and Immunity profile →
  4. A Molecular Basis for MHC Class II—Associated Autoimmunity
    1988 606 citations Michael McDermott et al. profile →
  5. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
    2014 602 citations Michael McDermott et al. profile →
  6. A Proposed Classification of the Immunological Diseases
    2006 557 citations Michael McDermott et al. profile →
  7. p38MAPK: stress responses from molecular mechanisms to therapeutics
    2009 525 citations Lydia Coulthard, Danielle E. White et al. Trends in Molecular Medicine profile →
  8. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations
    2009 511 citations Robert H. Dworkin, Dennis C. Turk et al. profile →
  9. Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss
    2014 351 citations Michael McDermott et al. profile →
  10. The Idiopathic Intracranial Hypertension Treatment Trial
    2014 290 citations Michael McDermott et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael McDermott United States 91 9.2k 6.4k 5.6k 3.8k 3.7k 630 33.4k
Harry V. Vinters United States 104 11.9k 1.3× 9.2k 1.4× 1.7k 0.3× 4.7k 1.2× 2.8k 0.8× 540 45.1k
John H. Zhang United States 94 11.8k 1.3× 14.0k 2.2× 3.1k 0.6× 6.3k 1.7× 2.5k 0.7× 1.1k 42.3k
Cornelia M. van Duijn Netherlands 96 11.8k 1.3× 4.7k 0.7× 1.4k 0.2× 3.2k 0.8× 1.7k 0.5× 676 40.3k
Ulrich Dirnagl Germany 99 8.9k 1.0× 5.4k 0.8× 3.2k 0.6× 4.9k 1.3× 1.7k 0.5× 388 35.1k
James S. Babb United States 95 2.5k 0.3× 2.8k 0.4× 3.0k 0.5× 4.2k 1.1× 6.4k 1.7× 520 33.0k
Thomas F. Lüscher Switzerland 127 11.6k 1.3× 1.7k 0.3× 5.5k 1.0× 4.4k 1.2× 6.3k 1.7× 1.1k 62.6k
Xiang Gao China 88 10.1k 1.1× 2.8k 0.4× 3.3k 0.6× 4.2k 1.1× 1.6k 0.4× 779 29.5k
Elisabeth G.E. de Vries Netherlands 102 14.3k 1.6× 3.1k 0.5× 4.3k 0.8× 6.1k 1.6× 7.4k 2.0× 1.0k 47.8k
Josef Penninger Austria 133 40.9k 4.4× 4.0k 0.6× 18.0k 3.2× 5.1k 1.3× 3.1k 0.9× 582 78.3k
Yi Zhang China 81 16.5k 1.8× 7.5k 1.2× 12.8k 2.3× 4.7k 1.2× 5.7k 1.5× 1.3k 57.3k

Countries citing papers authored by Michael McDermott

Since Specialization
Citations

This map shows the geographic impact of Michael McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael McDermott more than expected).

Fields of papers citing papers by Michael McDermott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael McDermott. The network helps show where Michael McDermott may publish in the future.

Co-authorship network of co-authors of Michael McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of Michael McDermott. A scholar is included among the top collaborators of Michael McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael McDermott. Michael McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lara‐Reyna, Samuel, James A. Poulter, Elton J. R. Vasconcelos, et al.. (2020). Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease. Journal of Clinical Immunology. 41(2). 441–457. 4 indexed citations
2.
Caseley, Emily A., James A. Poulter, François Rodrigues, & Michael McDermott. (2020). Inflammasome inhibition under physiological and pharmacological conditions. Genes and Immunity. 21(4). 211–223. 34 indexed citations
3.
Standing, Ariane, Ying Hong, Coro Paisán‐Ruiz, et al.. (2019). TRAP1 chaperone protein mutations and autoinflammation. Life Science Alliance. 3(2). e201900376–e201900376. 12 indexed citations
4.
Scambler, Thomas, Heledd Jarosz-Griffiths, Samuel Lara‐Reyna, et al.. (2019). ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis. eLife. 8. 86 indexed citations
5.
Han, Dae Yup, Lijun Ma, Steve Braunstein, et al.. (2018). Resection Cavity Contraction Effects in the Use of Radioactive Sources (1-25 versus Cs-131) for Intra-Operative Brain Implants. Cureus. 10(1). e2079–e2079. 14 indexed citations
6.
Baker, Joseph F., et al.. (2014). Congenital-infantile fibrosarcoma of the foot--avoidance of amputation.. PubMed. 107(5). 148–9.
7.
Gewandter, Jennifer S., Andrew McKeown, Michael McDermott, et al.. (2014). Data Interpretation in Analgesic Clinical Trials With Statistically Nonsignificant Primary Analyses: An ACTTION Systematic Review. Journal of Pain. 16(1). 3–10. 36 indexed citations
8.
Wieduwilt, Matthew J., Francisco Valles, Samar Issa, et al.. (2012). Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI. Clinical Cancer Research. 18(4). 1146–1155. 99 indexed citations
9.
Kartalija, Marinka, Alida R. Ovrutsky, Gregory B. Pott, et al.. (2012). Patients with Nontuberculous Mycobacterial Lung Disease Exhibit Unique Body and Immune Phenotypes. American Journal of Respiratory and Critical Care Medicine. 187(2). 197–205. 169 indexed citations
10.
Glanzman, Allan M., Michael McDermott, Jacqueline Montes, et al.. (2011). Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatric Physical Therapy. 23(4). 322–326. 95 indexed citations
11.
Coulthard, Lydia, Danielle E. White, Dominic Jones, Michael McDermott, & Susan A. Burchill. (2009). p38MAPK: stress responses from molecular mechanisms to therapeutics. Trends in Molecular Medicine. 15(8). 369–379. 525 indexed citations breakdown →
12.
Parsa, Andrew T., Courtney A. Crane, Sean Wilson, et al.. (2007). Autologous tumor derived gp96 evokes a tumor specific immune response in recurrent glioma patients that correlates with clinical response to therapy. Molecular Cancer Therapeutics. 6. 9 indexed citations
13.
Rubenstein, James L., Jane Fridlyand, Lauren E. Abrey, et al.. (2007). Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma. Journal of Clinical Oncology. 25(11). 1350–1356. 243 indexed citations
14.
Stallings, Raymond L., Prakash Nair, John M. Maris, et al.. (2006). High-Resolution Analysis of Chromosomal Breakpoints and Genomic Instability Identifies PTPRD as a Candidate Tumor Suppressor Gene in Neuroblastoma. Cancer Research. 66(7). 3673–3680. 97 indexed citations
15.
McMahon, Colin J., Michael McDermott, & Kevin Walsh. (2006). Failure of cutting balloon angioplasty to prevent restenosis in childhood pulmonary venous stenosis. Catheterization and Cardiovascular Interventions. 68(5). 763–766. 7 indexed citations
16.
Touitou, Isabelle, Suzanne Lesage, Michael McDermott, et al.. (2004). Infevers: An evolving mutation database for auto-inflammatory syndromes. Human Mutation. 24(3). 194–198. 234 indexed citations
17.
Lachmann, Helen J., Michael McDermott, & Philip N. Hawkins. (2003). AA amyloidosis complicating the hereditary periodic fever syndromes.. UCL Discovery (University College London). 8 indexed citations
18.
Vedhara, Kavita, Michael McDermott, Thomas G. Evans, et al.. (2002). Chronic stress in nonelderly caregivers. Journal of Psychosomatic Research. 53(6). 1153–1161. 68 indexed citations
19.
Guzey, V., et al.. (2001). Revealing the black body regime of small x DIS through final state signals. arXiv (Cornell University). 1 indexed citations
20.
Mullarkey, M., et al.. (2001). Genetic abnormalities in a pre and post-chemotherapy hepatoblastoma. Cytogenetic and Genome Research. 95(1-2). 9–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harry V. Vinters Breakdown of academic impact, for papers by John H. Zhang Breakdown of academic impact, for papers by Cornelia M. van Duijn Breakdown of academic impact, for papers by Ulrich Dirnagl Breakdown of academic impact, for papers by James S. Babb Breakdown of academic impact, for papers by Thomas F. Lüscher Breakdown of academic impact, for papers by Xiang Gao Breakdown of academic impact, for papers by Elisabeth G.E. de Vries Breakdown of academic impact, for papers by Josef Penninger Breakdown of academic impact, for papers by Yi Zhang
Rankless by CCL
2026